Powerful Medical
Powerful Medical is a leader in AI-driven cardiovascular diagnostics, dedicated to revolutionizing the detection and treatment of heart diseases. Their flagship product, PMcardio, is a CE-certified AI platform that interprets ECGs to assess 49 cardiac conditions rapidly and accurately. Trusted by over 100,000 clinicians and validated in more than 15 studies, the company aims to improve patient outcomes worldwide through innovative, data-driven solutions. Established in 2017, Powerful Medical is backed by a scientific board of renowned cardiologists and a multidisciplinary team of physicians, data scientists, AI experts, and regulatory specialists. The company is actively expanding its global presence, forming strategic partnerships, and continuously validating its AI models through extensive clinical research.
Industries
Nr. of Employees
medium (51-250)
Powerful Medical
Powerful Medical, 123 Medical Lane, City, Country
Patents
Methods for generating an undistorted image from a distorted original image of a graphical representation
US-12614244-B2
View Details
Methods for generating an undistorted image from a distorted original image of a graphical representation
US-12614244-B2
View DetailsProducts
Mobile ECG interpretation application
Smartphone application that digitizes photographed 12‑lead ECGs, returns automated ECG interpretations, and provides visual explainability to support point-of-care decisions.
Enterprise ECG analysis and care-coordination platform
Dashboard and backend platform that ingests ECGs, performs automated analysis, stores centralized reports, and integrates with clinical systems for hospital-scale use.
Occlusion-focused ECG detection module
Algorithmic module optimized to detect occlusive myocardial infarction and related equivalent ECG patterns with improved sensitivity compared to traditional criteria.
ECG-derived LVEF estimation module
AI module that estimates probability of reduced left ventricular ejection fraction from 12‑lead ECG inputs to aid screening where echocardiography is not immediately available.
Regulatory-certified ECG diagnostic software (multi-condition)
Regulatory-certified clinical ECG diagnostic software that provides automated assessment across a broad set of cardiac conditions and has been subject to multi-study clinical validation.
Mobile ECG interpretation application
Smartphone application that digitizes photographed 12‑lead ECGs, returns automated ECG interpretations, and provides visual explainability to support point-of-care decisions.
Enterprise ECG analysis and care-coordination platform
Dashboard and backend platform that ingests ECGs, performs automated analysis, stores centralized reports, and integrates with clinical systems for hospital-scale use.
Occlusion-focused ECG detection module
Algorithmic module optimized to detect occlusive myocardial infarction and related equivalent ECG patterns with improved sensitivity compared to traditional criteria.
ECG-derived LVEF estimation module
AI module that estimates probability of reduced left ventricular ejection fraction from 12‑lead ECG inputs to aid screening where echocardiography is not immediately available.
Regulatory-certified ECG diagnostic software (multi-condition)
Regulatory-certified clinical ECG diagnostic software that provides automated assessment across a broad set of cardiac conditions and has been subject to multi-study clinical validation.
Services
Onboarding, connectors for EHRs and ECG devices, user and location administration, and deployment of AI ECG analysis integrated into hospital workflows.
Design and operational support for prospective and retrospective multi-center validations and collaborative research to generate regulatory-grade evidence and publications.
Implementation of configurable clinician notification systems and activation workflows, including manual and automatic alerts for emergency and prehospital teams.
Implementation and maintenance of information security, privacy controls and supporting documentation aligned with international standards and regional healthcare regulations.
Clinician education and engagement through webinars and training sessions on ECG diagnosis and management topics to support clinical adoption and knowledge transfer.
Onboarding, connectors for EHRs and ECG devices, user and location administration, and deployment of AI ECG analysis integrated into hospital workflows.
Design and operational support for prospective and retrospective multi-center validations and collaborative research to generate regulatory-grade evidence and publications.
Implementation of configurable clinician notification systems and activation workflows, including manual and automatic alerts for emergency and prehospital teams.
Implementation and maintenance of information security, privacy controls and supporting documentation aligned with international standards and regional healthcare regulations.
Clinician education and engagement through webinars and training sessions on ECG diagnosis and management topics to support clinical adoption and knowledge transfer.
Expertise Areas
- Clinical AI for ECG interpretation
- Acute coronary occlusion detection and triage (OMI/STEMI equivalents)
- Clinical validation and multi-center study coordination
- Medical device regulatory strategy and CE/UK registration
Key Technologies
- Deep neural networks for ECG analysis
- Image-to-signal ECG digitization and preprocessing
- Lead-level explainability visualizations
- Cloud-based deployment and APIs for EHR integration
News & Updates
Alphaiota and PMcardio expand their partnership to bring AI-powered heart attack diagnostics to Saudi Arabia, with PMcardio as the exclusive regional distributor.
The company received over €985,000 in funding to develop AI-based ECG interpretation technology for early diagnosis of acute coronary syndromes.
The company announced that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the FDA, recognizing it as a significant advancement in detecting life-threatening cardiac conditions.
In March 2023, Powerful Medical launched PMcardio, a CE-certified AI platform for ECG interpretation, marking a milestone in cardiovascular diagnostics.
Development of the 'Queen of Hearts' AI model to detect occlusion myocardial infarction faster and with higher sensitivity, improving early diagnosis and saving lives.
Alphaiota and PMcardio expand their partnership to bring AI-powered heart attack diagnostics to Saudi Arabia, with PMcardio as the exclusive regional distributor.
The company received over €985,000 in funding to develop AI-based ECG interpretation technology for early diagnosis of acute coronary syndromes.
The company announced that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the FDA, recognizing it as a significant advancement in detecting life-threatening cardiac conditions.
In March 2023, Powerful Medical launched PMcardio, a CE-certified AI platform for ECG interpretation, marking a milestone in cardiovascular diagnostics.
Development of the 'Queen of Hearts' AI model to detect occlusion myocardial infarction faster and with higher sensitivity, improving early diagnosis and saving lives.